Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Jan 2011 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Kotak Large Cap Fund |
|---|---|
| 03 Jan 2011 | ₹100.00 |
| 23 Apr 2012 | ₹78.31 |
| 11 Aug 2013 | ₹80.54 |
| 30 Nov 2014 | ₹127.99 |
| 20 Mar 2016 | ₹92.02 |
| 08 Jul 2017 | ₹104.92 |
| 27 Oct 2018 | ₹87.20 |
| 15 Feb 2020 | ₹98.85 |
| 04 Jun 2021 | ₹124.84 |
| 23 Sep 2022 | ₹138.16 |
| 12 Jan 2024 | ₹176.67 |
| 01 May 2025 | ₹204.47 |
| 20 Aug 2026 | ₹213.24 |
| Metric | Kotak Mahindra · Regular · IDCW NAV ₹73.88 Very High risk ★★★★☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -0.35% | -5.49% | |
| +11.26% | +7.73% | |
| +9.97% | +6.21% | |
| +7.67% | +4.02% | |
| +4.96% | +5.54% | |
| +9.29% | — | |
| +7.37% | +6.92% | |
| +6.16% | +6.12% | |
| +5.90% | +3.99% | |
| Risk | ||
| 13.12% | 14.74% | |
| 0.36 | 0.02 | |
| 0.50 | 0.03 | |
| -54.40% | -48.01% | |
| Nifty 100 | — | |
| +1.21% | -1.74% | |
| 0.97 | 0.98 | |
| 101.8% | 93.8% | |
| 95.1% | 102.3% | |
| 1.84% | 2.38% | |
| ₹10,378Cr | ₹1,495Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 58% | |
| Rohit Tandon · 2.6y | — | |
| 03 Jan 2011 | — | |
| 60 | — | |
| 45.3% | — | |
| 1.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.